Breaking News Instant updates and real-time market news.

FMS

Fresenius Medical

$32.21

-2.05 (-5.98%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03

Redburn downgrades Fresenius Medical to Neutral on growth concerns

Redburn analyst Ed Ridley-Day downgraded Fresenius Medical Care to Neutral from Buy and lowered his implied fair value estimate to 68 euros from 81 euros. Fresenius may not be able to achieve a return to high-single-digit earnings growth with pressure on margins likely to persist, Ridley-Day tells investors in a research note. He sees increasing risks around the company's U.S. dialysis business and limited potential recovery in Care Coordination.

  • 29

    Oct

FMS Fresenius Medical
$32.21

-2.05 (-5.98%)

11/20/18
RHCO
11/20/18
NO CHANGE
Target $46
RHCO
Buy
Fresenius Medical price target lowered to $46 from $62 at SunTrust
SunTrust analyst David MacDonald lowered his price target on Fresenius Medical to $46 to reflect its "soft" Q3 results with a lower implied valuation of 10-times forward EBITDA. The analyst believes that given the mixed fundamentals, the stock is a "show me" story, even though he keeps his Buy rating on Fresenius Medical longer term based on its "solid core volume trends, attractive overarching industry drivers, a diversified business model, and strong free cash generation".
02/21/19
RHCO
02/21/19
NO CHANGE
Target $48
RHCO
Buy
Fresenius Medical price target raised to $48 from $40 at SunTrust
SunTrust analyst David MacDonald raised his price target on Fresenius Medical to $48 and kept his Buy rating after its Q4 results yesterday, saying the quarter was "marked by solid organic trends, ongoing efficiency gains and strong cash flow." The analyst anticipates the company's 2019 to be a year of investment but sees the incremental spending driving more optimization and positioning Fresenius Medical for "attractive growth opportunities". MacDonald adds that he is positive on the company's pending acquisition of NxStage Medical (NXTM) given the market shift "towards the home".
06/20/19
LEHM
06/20/19
UPGRADE
LEHM
Overweight
Fresenius Medical upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Hassan Al-Wakeel upgraded Fresenius Medical Care to Overweight from Equal Weight and raised his price target for the shares to 81.50 euros from 71 euros. After speaking with CEO Rice Powell and a deep-dive into U.S. dialysis market fundamentals, the analyst believes market concerns around the medium-term sustainability of growth are likely overdone. The analyst has started to see some improvements in the business and believes expectations are now achievable. He now sees a "compelling" risk/reward over the medium term for shares of Fresenius Medical.
10/23/19
REDB
10/23/19
DOWNGRADE
REDB
Neutral
Fresenius Medical downgraded to Neutral from Buy at Redburn
Redburn analyst Ed Ridley-Day downgraded Fresenius Medical Care to Neutral from Buy.

TODAY'S FREE FLY STORIES

AMX

America Movil, also tag AMOV

$15.92

0.02 (0.13%)

, AMOV

America Movil, also tag AMX

$15.70

(0.00%)

15:46
11/11/19
11/11
15:46
11/11/19
15:46
Periodicals
Mexican regulator probing 'monopolistic' mobile phone practices, Bloomberg says »

The IFT investigative…

AMX

America Movil, also tag AMOV

$15.92

0.02 (0.13%)

AMOV

America Movil, also tag AMX

$15.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$2.94

-0.165 (-5.31%)

15:37
11/11/19
11/11
15:37
11/11/19
15:37
Hot Stocks
Mallinckrodt says Phase 3 CONFIRM study met primary endpoint »

Mallinckrodt announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

FGEN

FibroGen

$35.69

-5.92 (-14.23%)

15:34
11/11/19
11/11
15:34
11/11/19
15:34
Options
FibroGen options imply 13.7% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

FNV

Franco-Nevada

$95.70

0.09 (0.09%)

15:19
11/11/19
11/11
15:19
11/11/19
15:19
Options
Franco-Nevada options imply 4.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MNST

Monster Beverage

$57.81

-0.38 (-0.65%)

15:17
11/11/19
11/11
15:17
11/11/19
15:17
Recommendations
Monster Beverage analyst commentary  »

Monster Beverage said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/11/19
11/11
15:17
11/11/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
11/11/19
11/11
15:16
11/11/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$29.63

-0.45 (-1.50%)

15:04
11/11/19
11/11
15:04
11/11/19
15:04
Options
DXC Technology options imply 23.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

MRK

Merck

$83.09

-0.5 (-0.60%)

15:01
11/11/19
11/11
15:01
11/11/19
15:01
Hot Stocks
Merck reports ERVEBO vaccine granted conditional approval in EU »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

BTI

British American Tobacco

$37.41

0.38 (1.03%)

, MO

Altria Group

$46.49

0.08 (0.17%)

14:51
11/11/19
11/11
14:51
11/11/19
14:51
Hot Stocks
Trump says will meet with representatives of the vaping industry »

U.S. President Donald…

BTI

British American Tobacco

$37.41

0.38 (1.03%)

MO

Altria Group

$46.49

0.08 (0.17%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$83.70

0.11 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

WMGI

Wright Medical

$29.39

-0.01 (-0.03%)

14:49
11/11/19
11/11
14:49
11/11/19
14:49
Options
Wright Medical options imply 3.5% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COG

Cabot Oil & Gas

$17.86

-0.515 (-2.80%)

14:45
11/11/19
11/11
14:45
11/11/19
14:45
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.72

-0.08 (-0.15%)

, USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

14:27
11/11/19
11/11
14:27
11/11/19
14:27
Periodicals
Total CEO sees weak oil demand growth next year, Bloomberg says »

Total CEO Patrick…

TOT

Total

$54.72

-0.08 (-0.15%)

USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

, ACN

Accenture

$189.95

0.34 (0.18%)

14:25
11/11/19
11/11
14:25
11/11/19
14:25
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

ACN

Accenture

$189.95

0.34 (0.18%)

WPP

WPP

$64.60

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

WPP

WPP

$64.60

-0.01 (-0.02%)

, ACN

Accenture

$190.05

0.44 (0.23%)

14:21
11/11/19
11/11
14:21
11/11/19
14:21
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

WPP

WPP

$64.60

-0.01 (-0.02%)

ACN

Accenture

$190.05

0.44 (0.23%)

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

MS

Morgan Stanley

$49.30

0.15 (0.31%)

14:20
11/11/19
11/11
14:20
11/11/19
14:20
Options
Heavy bullish option flow in Morgan Stanley January term »

Heavy bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

BABA

Alibaba

$186.42

-0.69 (-0.37%)

, AAPL

Apple

$261.99

1.79 (0.69%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Hot Stocks
Alibaba reports 11.11 gross merchandise volume grew 26% year-over-year to $38.4B »

Alibaba Group (BABA)…

BABA

Alibaba

$186.42

-0.69 (-0.37%)

AAPL

Apple

$261.99

1.79 (0.69%)

EL

Estee Lauder

$186.46

-0.81 (-0.43%)

GPS

Gap

$17.01

0.32 (1.92%)

LRLCY

L'Oreal

$0.00

(0.00%)

LEVI

Levi Strauss

$17.07

-0.06 (-0.35%)

NSRGY

Nestle

$0.00

(0.00%)

NKE

Nike

$89.89

0.09 (0.10%)

VFC

VF Corp.

$86.52

-0.56 (-0.64%)

UA

Under Armour

$15.81

-0.07 (-0.44%)

UAA

Under Armour

$17.53

-0.02 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 21

    Nov

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/11/19
11/11
14:16
11/11/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$6.05

-0.42 (-6.49%)

14:13
11/11/19
11/11
14:13
11/11/19
14:13
Periodicals
CA governor raises objections to $11B PG&E insurance deal, WSJ reports »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 07

    Jan

AUPH

Aurinia Pharmaceuticals

$5.05

-0.085 (-1.66%)

14:05
11/11/19
11/11
14:05
11/11/19
14:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

LPCN

Lipocine

$0.78

-1.945 (-71.38%)

14:04
11/11/19
11/11
14:04
11/11/19
14:04
Recommendations
Lipocine analyst commentary  »

Lipocine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.93

-0.13 (-1.84%)

13:55
11/11/19
11/11
13:55
11/11/19
13:55
Options
Fitbit put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.61

-0.02 (-0.26%)

13:45
11/11/19
11/11
13:45
11/11/19
13:45
Options
Deutsche Bank call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.82

-1.9039 (-69.87%)

13:37
11/11/19
11/11
13:37
11/11/19
13:37
Downgrade
Lipocine rating change at Ladenburg »

Lipocine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.